Senya Therapeutics

📍 London, United Kingdom👥 7 employees💰 Last funded Apr 2024
Developing first-in-class LRG inhibitor to harness pathogenic effect of TGF-β cascade in chronic kidney disease and cancer | a spin-out from University College London
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Senya Therapeutics?
Senya Therapeutics has 1 investors on record on gritt.io.
When did Senya Therapeutics last raise funding?
The most recent investment in Senya Therapeutics recorded on gritt.io was in April 2024.
What industry is Senya Therapeutics in?
Senya Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Senya Therapeutics based?
Senya Therapeutics is headquartered in London, United Kingdom.